Resourcing issues

European Journal of Endocrinology, Supplement

Volumn 151, Issue 2, 2004, Pages

  Gagliardino, Juan José ^a  

^a University of La Plata CONICET   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CAREGIVER; CHRONIC DISEASE; COMMUNITY CARE; CONFERENCE PAPER; COOPERATION; DIABETES MELLITUS; DRUG INDUSTRY; FAMILY; GOVERNMENT; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH EDUCATION; HEART REHABILITATION; HUMAN; MEDICAL EDUCATION; PATIENT ATTITUDE; PATIENT EDUCATION; PRIMARY PREVENTION; RESOURCE MANAGEMENT; SECONDARY PREVENTION;

DIABETES MELLITUS; HEALTH RESOURCES; HUMANS; QUALITY OF HEALTH CARE;

EID: 8644273899     PISSN: 08044635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Jonsson B. The economic impact of diabetes. Diabetes Care 1998 21 (Suppl) C7-C10.
2. Williams R, Van Gaal L & Lucioni C. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002 45 S13-S17.
3. King H, Aubert RE & Herman WH. Global burden of diabetes 1995-2025. Diabetes Care 1998 21 1414-1431.
4. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practices in the diabetes control and complications trial. Journal of the American Medical Association 1996 276 1409-1415.
5. Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C. Stratton I, Adler A, Holman R & Turner R. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. British Medical Journal 2000 320 1373-1378.
6. Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W, Dong F & Manninen D. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 1997 20 735-744.
7. The CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. Journal of the American Medical Association 2002 287 2542-2551.
8. Karter AJ, Stevens MR, Herman WH, Ettner S, Marrero DG, Safford MM, Engelgan MM, Curb JD & Brown AF; Translating Research into Action for Diabetes Study Group. Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2003 26 2294-2299.
9. Saddine J, Engelagu M, Beckles G, Gregg E & Thompson T. A diabetes report card for the United States: quality of care in the 1990s. Annals of Internal Medicine 2002 136 565-574.
10. Gagliardino JJ, de la Hera M, Siri F & y Grupo de Investigacion de la Red Qualidiab. Evaluacion de la calidad de la asistencia al paciente diabetico en America Latina. Revista Panamericana de Salud Pública/Pan American Journal of Public Health 2001 10 309-317 [Article in Spanish and English].
11. Gagliardino J & Olivera E. The regions and their health care systems: Latin America. In Economics of Diabetes and Diabetes Care. A report of the Diabetes Health Economics Study Group, pp 51-59. Eds W Gruber, T Lander, B Leese, T Songer & H Williams. Brussels: International Diabetes Federation, 1997.
12. Grandjour A, Kleinschmit F & Lauterbach KW. INTERCARE International Investigators. European comparison of costs and quality in the prevention of secondary complications in type 2 diabetes mellitus (2000-2001). Diabetic Medicine 2002 19 594-601.
13. Gagliardino JJ, Jadzinsky M, Alvarinas J, Fabiano A, Sereday M, Sinay I and the PROCAMEG Research Group. Sociedad Argentina de Diabetes. Programa de capacitacion diabetologica para medicos generalistas (PROCAMEG). Revista de la Sociedad Argentina de Diabetes 1998 32 205-210 [Article in Spanish].
14. Gagliardino J, Etchegoyen G & the PEDNID-LA Research Group. A model education program for people with type 2 diabetes: a cooperative Latin-American implementation study. Diabetes Care 2001 24 1001-1007.
15. Gagliardino J, Olivera E, Etchegoyen G, Guidi ML, Martella A, Caporale JE, De La Hera M, Siri F and Bonelli P (2001) Control y prevención secundaria para personas con diabetes: impacto de la implementación de un programa de atención (PROPAT). Revista de la Sociedad Argentina de Diabetes 35 77-86 [Article in Spanish].
16. Pan X, Li G, Hu Y-H, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Lui PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH & Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997 20 537-544.
17. Diabetes Prevention Program Research Group. Reduction in the incidence of type II diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002 346 393-403.
18. Tuomilehto J, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kivkoannlemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 344 1343-1350.